BenchSci

OverviewSuggest Edit

BenchSci is a provider of a reagent intelligence platform designed to pair scientists with reagents they need for experiments. The platform uses machine learning software that transforms published data into experiment-specific recommendations to reduce time, money and uncertainty in planning materials and methods in the form of published figures, decoding papers and making the data easily discoverable, enabling scientists and researchers to find antibody usage data.

TypePrivate
Founded2015
HQToronto, CA
Websitebenchsci.com
Employee Ratings5

Latest Updates

Employees (est.) (Nov 2020)132
Cybersecurity ratingCMore

Key People/Management at BenchSci

Rasheed Ahmed

Rasheed Ahmed

Head of Operations
Liran Belenzon

Liran Belenzon

CEO and Co-Founder
Luigi Gentile

Luigi Gentile

Chief Revenue Officer
Bryn Knox

Bryn Knox

Head of Finance
Mark Kostove

Mark Kostove

Enterprise Sales Executive
Stephanie Prezioso

Stephanie Prezioso

Associate Product Manager
Show more

BenchSci Office Locations

BenchSci has an office in Toronto
Toronto, CA (HQ)
201 559 College St
Toronto, CA
711 Bay St
Show all (2)

BenchSci Financials and Metrics

Summary Metrics

Founding Date

2015

BenchSci total Funding

$35.1 m

BenchSci latest funding size

$22 m

Time since last funding

10 months ago

BenchSci investors

BenchSci's latest funding round in February 2020 was reported to be $22 m. In total, BenchSci has raised $35.1 m
Show all financial metrics

BenchSci Operating Metrics

BenchSci's Enterprise Customers was reported to be 15 in Feb, 2020.
Feb, 2020

Enterprise Customers

15

Products Registered

7.70 m

Vendors

231
Show all operating metrics

BenchSci Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

BenchSci Online and Social Media Presence

Embed Graph

BenchSci News and Updates

BenchSci Certified as Great Place to Work® and Listed as Best Startup Workplace

Certification reflects mission to exponentially increase the speed and quality of life-saving research, and focus on employee health and wellness

AI-Derived COVID-19 Experimental Data and Reagent Insights Now Available From BenchSci to Accelerate R&D Efforts

Open-access data will help scientists select antibody, RNAi, and protein reagents to expedite development of treatments and vaccines

BenchSci raises $29 million CAD Series B round

BenchSci has raised a $29 million CAD ($22 million USD) Series B funding round led by F-Prime Capital. The financing round also saw participation...

BenchSci raises $22 million for AI-powered drug discovery tools

BenchSci, a Toronto-based startup developing an AI-powered platform for drug discovery, has raised $22 million in venture capital.

Gradient Ventures backs BenchSci

Gradient Ventures has made an additional investment in BenchSci, bringing the latter company's total funding to $20.5 million. Based in Toronto, BenchSci is an AI-assisted antibody selection platform.

GeneTex Partners With BenchSci to Augment Antibody Catalog Publication Data

Partnership will use BenchSci's artificial intelligence to help researchers run successful experiments with the right antibody

BenchSci Blogs

Expanded Antibody Validation and More New Features on BenchSci

At BenchSci, we’re always looking for new ways our technology can help you design and run more successful experiments. Over the last few months we launched even more new features that you’ve asked for to our AI-Assisted Antibody Selection and AI-Assisted Reagent Selection products. Read …

Lessons Learned from Interviewing More than 500 Software Engineers over the Last Three Years

Over the last three years, I’ve had the opportunity to interview more than 500 software engineers and the pleasure of hiring over 50 of them. During that time, I’ve witnessed countless situations where candidates struggled with a few key elements that could have easily been improved with…

Why We Prioritize Our Employees’ Mental Health

October 10th is World Mental Health Day, and as a health-focused company, we’re passionate about ensuring the mental health of our employees. Almost 20% of adults suffer from mental health issues each year, and more than 70% experience at least one symptom of stress. Worldwide acknowledg…

Cell Products Now on BenchSci!

Cell and cell line products form an integral part of the experimental process by allowing scientists to study biological processes in a controlled environment. Because of their importance to research, scientists across a wide range of fields and disciplines use cell products in their wor…

We Remotely Onboarded 29 New Employees During COVID-19. Here’s How.

At BenchSci, we’re always looking to answer the question, “how can we do things better?” And our new hire onboarding experience is no exception. We continually craft our onboarding journey to create a welcoming environment while simultaneously enabling new employees to hit the ground run…

Find antibodies verified according to the 5 Nature pillars of validation, plus 2 additional pillars

Antibodies are the most commonly used reagents in life science research. However, reproducibility issues caused by inappropriate antibodies are contributing to Avoidable Experiment Expenditure, where time and resources are spent on unsuccessful experiments and unverifiable conclusions, d…
Show more

BenchSci Frequently Asked Questions

  • When was BenchSci founded?

    BenchSci was founded in 2015.

  • Who are BenchSci key executives?

    BenchSci's key executives are Rasheed Ahmed, Liran Belenzon and Luigi Gentile.

  • How many employees does BenchSci have?

    BenchSci has 132 employees.

  • Who are BenchSci competitors?

    Competitors of BenchSci include Semarchy, Datasembly and Health IQ.

  • Where is BenchSci headquarters?

    BenchSci headquarters is located at 201 559 College St, Toronto.

  • Where are BenchSci offices?

    BenchSci has an office in Toronto.

  • How many offices does BenchSci have?

    BenchSci has 2 offices.